Pharmaceutical and Life Sciences Law

Commercial interests and access to documents

Resolution 352/2020 of the Council of Transparency and Good Governance of 15 September 2020

Joan Carles Bailach

9 Nov 2020

Capsulas Nº 212

Draft law on procedural and organizational measures to confront the COVID-19 in the Administration of Justice

Xavier Moliner, Juan Martínez

17 Aug 2020

Capsulas Nº 210

Processing applications for access to documents

Resolutions 047/2020 and 137/2020 of the Council of Transparency and Good Governance (CTBG)

Joan Carles Bailach, Eduard Rodellar

17 Aug 2020

Capsulas Nº 210

Draft law on procedural and organizational measures to confront the COVID-19 in the Administration of Justice

Xavier Moliner, Juan Martínez

3 Aug 2020

Capsulas Nº 210

Processing applications for access to documents

Resolutions 047/2020 and 137/2020 of the Council of Transparency and Good Governance (CTBG)

Joan Carles Bailach, Eduard Rodellar

3 Aug 2020

Capsulas Nº 210

¿May medical visits be restricted? What about on-line visits? Medical visits face new challenges in the "new normality"

Jordi Faus, Eduard Rodellar and Lluís Alcover

22 May 2020

Capsulas Special Issue

The government approves to relax public procurement and corporate governance rules in view of Covid-19

Jordi Faus, Xavier Moliner, Lluís Alcover and Joan Carles Bailach

19 Mar 2020

Capsulas Special Issue

Spanish Government declares State of Emergency. How does this affect companies in the life sciences sector?

Jordi Faus, Lluís Alcover and Joan Carles Bailach

15 Mar 2020

Capsulas Special Issue

Messages on healthcare and pharma by the new Spanish Coalition Government in Spain

The PSOE-Unidas Podemos Coalition Program contains various relevant measures dedicated to healthcare and pharma

Jordi Faus, Joan Carles Bailach

3 Feb 2020

Capsulas Nº 207

Transparency of the documents submitted in the context of a marketing authorization application for a medicinal product

Judgments of the European Court of Justice of 20 January 2020, PTC Therapeutics v EMA, Case C-175/18 P; and MSD Animal Health Innovation and others v EMA, Case C-178/18 P

Jordi Faus

3 Feb 2020

‹ Previous 1 … 7 8 9 10 11 … 24 Next ›

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información. ACEPTAR

Aviso de cookies

Pharmaceutical and Life Sciences Law

Commercial interests and access to documents

Resolution 352/2020 of the Council of Transparency and Good Governance of 15 September 2020

Capsulas Nº 212

Rebus sic stantibus

Draft law on procedural and organizational measures to confront the COVID-19 in the Administration of Justice

Capsulas Nº 210

Processing applications for access to documents

Resolutions 047/2020 and 137/2020 of the Council of Transparency and Good Governance (CTBG)

Capsulas Nº 210

Rebus sic stantibus

Draft law on procedural and organizational measures to confront the COVID-19 in the Administration of Justice

Capsulas Nº 210

Processing applications for access to documents

Resolutions 047/2020 and 137/2020 of the Council of Transparency and Good Governance (CTBG)

Capsulas Nº 210

Medical visits and Covid-19

¿May medical visits be restricted? What about on-line visits? Medical visits face new challenges in the "new normality"

Capsulas Special Issue

The government approves to relax public procurement and corporate governance rules in view of Covid-19

Capsulas Special Issue

Spanish Government declares State of Emergency. How does this affect companies in the life sciences sector?

Capsulas Special Issue

Messages on healthcare and pharma by the new Spanish Coalition Government in Spain

The PSOE-Unidas Podemos Coalition Program contains various relevant measures dedicated to healthcare and pharma

Capsulas Nº 207

Transparency of the documents submitted in the context of a marketing authorization application for a medicinal product

Judgments of the European Court of Justice of 20 January 2020, PTC Therapeutics v EMA, Case C-175/18 P; and MSD Animal Health Innovation and others v EMA, Case C-178/18 P

Uso de cookies